Opciones terapéuticas frente a especies de Candida resistentes a las equinocandinas

Cortés Hidalgo, Andrea Patricia; Roa Dueñas, Oscar Hernando; Méndez Fandiño, Yardany Rafael; Álvarez-Moreno, Carlos A.
Univ. med ; 59(2): 1-15, 2018. ilus
Artigo em Espanhol | LILACS, COLNAL | ID: biblio-995812

Documentos relacionados

  1. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
  2. <i>Candida auris</i> Genetics and Emergence.
  3. Rapid development of Candida krusei echinocandin resistance during caspofungin therapy.
  4. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
  5. Antimicrobial Peptides with Anti-<i>Candida</i> Activity.
  6. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
  7. Treatment of invasive candidiasis in the era of Candida resistance.
  8. [Usefulness of the Sensititre YeastOne® panel to detect Candida species resistant to antifungal drugs].
  9. Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common <i>Candida</i> Species.
  10. Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility.